•  Optimization of necessary nonclinical studies for development and schedule
  •  Evaluation of nonclinical study data and go/no-go decision on drug development
  •  Suggestion of additional study designs to resolve issues
  •  Support of preparation of submission materials to regulatory authorities(IB, CTD, PMDA pre-consultation materials, interview  advice meeting materials, and response to queries from regulatory authorities)
  •  Participation in PMDA pre-consultation and interview advice meetings